Skip to content
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Search
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Advertise
NEWSLETTER
News
Data
Podcast
Clinics
EVENTS
News
Data
Podcast
Clinics
EVENTS
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
Investment
Biotech
Research
AI/Tech
Supplements
Clinics
Ecosystem
LT Wire
About
Contact
About
Contact
Advertise
nEWSLETTER
Search
Search
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Function, Google partner to...
Immorta Bio develops AI-des...
Phase 1b data show Rubedo L...
European consortium creates...
Avaí Bio, Austrianova, Ospe...
Alzheimer’s
Diagnostics
UK’s Alzheimer’s diagnosis gap gets a new fix
Biotech
Alzinova’s Alzheimer’s vaccine heads to CTAD stage
AI/Digital
Investment
Investment
UCLA lands $25m to test dementia AI tools
Diagnostics
Two very different Alzheimer’s tests just teamed up
AI/Digital
Biotech
Annovis turns to AI to fast-track its Alzheimer’s filing
Biotech
Lysoway drug tackles two brain diseases in mice
Biotech
NKGen presents new data on NK cell therapy targeting dementia
Biotech
Investment
Investment
Research
Oligomerix puts tau drug in new hands as trials begin
Biotech
Investment
Investment
Canada agrees to help pay for Alzheimer’s drug LEQEMBI
The latest longevity science, investment, innovation and insight, delivered every morning.
First Name
(Required)
Email Address
(Required)
Contact Source
Unlock Longevity Biotech Report for FREE
$617BN - Annual global revenue by 2045
$30BN+ - Invested in under 2 years
3,036 - Therapeutics individually assessed
Access full report
